Indaptus Therapeutics Inc.
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 18 institutions reported holding Indaptus Therapeutics Inc. in their 13F filings, down 3 from Q2 2024. 1 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($318K), Investment House LLC ($124K) and Geode Capital Management, LLC ($91K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Indaptus Therapeutics Inc.
- CUSIP
- 45339J105
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1 |
| Exits | 4 | $835 |
All 13F filers, Q2 2024 → Q3 2024: 15,053 shares bought and 9,947 shares sold, net +5,106 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Vanguard Group Inc. | 0.00% | No change | 256,265 | $318K |
| Investment House LLC | 0.01% | Reduce -2.4% | 99,976 | $124K |
| Geode Capital Management, LLC | 0.00% | Add +23.3% | 73,129 | $91K |
| Strategy Asset Managers LLC | 0.01% | No change | 45,336 | $56K |
| Pine Valley Investments Ltd Liability Co | 0.00% | Reduce -0.2% | 43,983 | $55K |
| Renaissance Technologies | 0.00% | Add +1.9% | 27,100 | $34K |
| Debussy Capital Management LP | 0.01% | No change | 24,000 | $30K |
| Citadel Advisors | 0.00% | Reduce -30.7% | 15,390 | $19K |
| State Street Corp. | 0.00% | No change | 13,073 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +17.3% | 4,812 | $6K |
| Morgan Stanley | 0.00% | No change | 884 | $1K |
| UBS Group AG | 0.00% | Reduce -24.6% | 522 | $647 |
| Bangor Savings Bank | 0.00% | No change | 400 | $496 |
| Wells Fargo & Company | 0.00% | No change | 64 | $79 |
| Bank of America Corp. | 0.00% | Add +42.9% | 60 | $74 |
| JPMorgan Chase & Co. | 0.00% | Add +26.7% | 19 | $24 |
| Group One Trading LLC | 0.00% | No change | 7 | $9 |
| Danske Bank A/S | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is INDAPTUS THERAPEUTICS INC's weight in each manager's 13F, not the share of Indaptus Therapeutics Inc. the manager owns.